The US Food and Drug Administration (FDA) has approved Alcyone Lifesciences' Alcyone MEMS Cannula (AMC), a neuro-ventricular cannula.
The device is intended for use in delivering gene therapy, therapeutic viruses, and other new ways of treating central nervous system disorders.
Electroencephalogram
An electroencephalogram (EEG) detects electrical activity in the brain using electrodes attached to the scalp.
Advertisement
The AMC is a dual-lumen, MRI-compatible injection and aspiration cannula for use in the brain. The AMC is not intended for implant, and it is intended for single patient use only.
Alcyone Lifesciences' Board member Richard Upton of Harbor Light Capital Partners
Said that he was thrilled for the Alcyone team.
"They are a highly talented and hard working group that has achieved this important company milestone in an efficient and skilled way. I look forward to helping them develop additional products and, ultimately, providing the best solutions for patients and their families," he said.
![Head Injury]( "Head Injury")
Head injury or traumatic brain injury is a leading cause of disability among children and young adults that leads to varying degrees of physical and mental stability. Fortunately, it is also one of the preventable brain disorder.
P.J. Anand, Founder & CEO of Alcyone Lifesciences said that the neuroscience community is pioneering new therapeutic agents including gene therapy, antibody and oncolytic biologic therapy that hold great promise in treating chronic CNS disorders.
"But unfortunately they have lacked a clinically effective technology for precise CNS delivery direct to a neurological target and for optimal bio-distribution. Given that the very potential of these new agents is dependent on optimal bio-distribution, it is our hope that the AMC will offer a solution for this critical unmet clinical need and further open the gates to novel therapeutic options for patients," he added.
Source: Medindia
"They are a highly talented and hard working group that has achieved this important company milestone in an efficient and skilled way. I look forward to helping them develop additional products and, ultimately, providing the best solutions for patients and their families," he said.
Head Injury
Head injury or traumatic brain injury is a leading cause of disability among children and young adults that leads to varying degrees of physical and mental stability. Fortunately, it is also one of the preventable brain disorder.
Advertisement
P.J. Anand, Founder & CEO of Alcyone Lifesciences said that the neuroscience community is pioneering new therapeutic agents including gene therapy, antibody and oncolytic biologic therapy that hold great promise in treating chronic CNS disorders.
"But unfortunately they have lacked a clinically effective technology for precise CNS delivery direct to a neurological target and for optimal bio-distribution. Given that the very potential of these new agents is dependent on optimal bio-distribution, it is our hope that the AMC will offer a solution for this critical unmet clinical need and further open the gates to novel therapeutic options for patients," he added.
Source: Medindia
Language Areas in The Brain
The mechanism of how human brain processes the language to express and comprehend the verbal, written, gestures and symbols is still a mystery.
Advertisement
 Brain TumorBrain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location. | Advertisement
|
Advertisement
Latest Medical Gadgets
Recent progress in the development of wearable devices has presented alternative ways for sleep monitoring at home, which could be useful in sleep apnea detection.
Researchers develop non-invasive brain imaging techniques to help people with disabilities.
Heart rate notifications and the ECG app on Apple Watch give patients and their clinicians' important information about their heart health.
The new machine learning tool prioritizes driver mutations in brain tumor (glioblastoma) and assists in identifying therapeutic targets.
KnitDema, the knitted robotic textile was found to show promising results for hand edema patients.